nitrendipine has been researched along with dazoxiben in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archibald, JL; Bradley, G; Ennis, C; Opalko, A; Shepperson, NB; Ward, TJ; White, JC | 1 |
| Ennis, C; Granger, SE; Middlefell, VC; Philpot, ME; Shepperson, NB | 1 |
2 other study(ies) available for nitrendipine and dazoxiben
| Article | Year |
|---|---|
Design of an antithrombotic-antihypertensive agent (Wy 27569). Synthesis and evaluation of a series of 2-heteroaryl-substituted dihydropyridines.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Chemical Phenomena; Chemistry; Dihydropyridines; Drug Design; Fibrinolytic Agents; Humans; Hypertension; Imidazoles; Nitrendipine; Rats; Rats, Inbred SHR; Structure-Activity Relationship; Thromboxane B2; Thromboxane-A Synthase | 1990 |
Pharmacologic effects of Wy 27569: a combined calcium channel blocker and thromboxane synthetase inhibitor.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; In Vitro Techniques; Male; Nitrendipine; Prostaglandins F; Rats; Rats, Inbred SHR; Thromboxane B2; Thromboxane-A Synthase | 1989 |